Page 2 - Junj Yang News Today

/PRNewswire/ -- Scientists at St. Jude Childrens Research Hospital are studying the impact of genetic ancestry on childhood acute lymphoblastic leukemia...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Jun J. Yang, Ph.D. and Shawn Lee, M.D., corresponding author and first author of the report published in JAMA Oncology. Scientists at St. Jude

/PRNewswire/ -- Scientists at St. Jude Childrens Research Hospital are studying the impact of genetic ancestry on childhood acute lymphoblastic leukemia...

Price: Scientists atSt. JudeChildren’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in The Lancet Oncology. Adding the chemotherapy vincristine plus a steroid (originally prednis...

Date Time Risk-directed childhood leukemia treatment takes a step forward Corresponding author Ching-Hon Pui, M.D., St. Jude Oncology Department chair, helped discover how genomic analysis can improve outcomes for children with acute lymphoblastic leukemia. Comprehensive genomic analyses have helped researchers identify more than 20 subtypes of acute lymphoblastic leukemia (ALL) based on the genetic mutations that drive the disease. Research led by St. Jude Children’s Research Hospital scie...

Corresponding author Ching-Hon Pui, M.D., chair of the St. Jude Department of Oncology, contributed to international research that helps predict and...